Biomarker - a sub study of the Calcium and pre-eclampsia clinical trial

Glaxosmithkline Research & Development Limited, Brentford, Middlesex, UK (GSK) has tasked ECRU to conduct a sub study of their current Calcium Study to evaluate the role of Calcium in pre-eclampsia through analysis of putative protein markers.

The objective of the study is to investigate if calcium supplementation during pre-conception and continued throughout the entire pregnancy will demonstrably alter pre-eclamsia pathology.We will assess this through the monitoring of prognostic protein markers of the disease.

This study will be conducted at Cecilia Makiwane and Frere Maternity Hospitals, East London, Eastern Cape, South Africa.

Start date 2015.